Inicio › Cáncer de seno › Wisconsin › Milwaukee
Ensayos clínicos de Cáncer de seno en Milwaukee, WI
23 estudios para Cáncer de seno buscan participantes en centros de Milwaukee y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Zablocki Veterans Administration Medical Center, Milwaukee
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- y 9 más
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
ReclutandoFase 1
- Research Site, Milwaukee
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
ReclutandoFase 3
- Clinical Trial Site, Milwaukee
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ReclutandoFase 3
- Medical College of Wisconsin, Milwaukee
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
ReclutandoFase 1/2
- Froedtert & MCW Cancer Center, Milwaukee
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ReclutandoFase 3
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
ReclutandoFase 2
- Medical College of Wisconsin, Milwaukee
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ReclutandoFase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- y 8 más
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
ReclutandoFase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
Reclutando
- Froedtert Hospital, Milwaukee
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer
Reclutando
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
E-Mindfulness Approaches for Living After Breast Cancer
ReclutandoFase 3
- UW Cancer Center at ProHealth Care, Waukesha · A 17 mi de distancia
- ProHealth D N Greenwald Center, Mukwonago · A 25 mi de distancia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
ReclutandoFase 3
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Medical College of Wisconsin, Milwaukee
- y 9 más
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- Aurora Cancer Care-Milwaukee, Milwaukee
- Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- y 10 más
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
ReclutandoEstudio observacional
- Medical College of Wisconsin, Milwaukee
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
ReclutandoFase 1
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
ReclutandoEstudio observacional
- Aurora Cancer Care - Wauwatosa, Wauwatosa · A 5 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Milwaukee
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer
ReclutandoFase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Individuals on Hormone Therapy Breast Cancer Screening Pilot
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Medical College of Wisconsin, Milwaukee
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
ReclutandoEstudio observacional
- Columbia St. Mary's, Milwaukee
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Reclutando
- Medical College of Wisconsin, Milwaukee
Más información sobre Cáncer de seno en MedlinePlus
Ensayos de Cáncer de seno en otras ciudades
- New York City, NY136 estudios
- Houston, TX126 estudios
- Boston, MA112 estudios
- Nashville, TN81 estudios
- Los Angeles, CA73 estudios
- Edison, NJ68 estudios
- St. Louis, MO64 estudios
- Queens, NY64 estudios
- Durham, NC64 estudios
- Chicago, IL59 estudios
- Philadelphia, PA56 estudios
- Dallas, TX55 estudios
Otros estudios en Milwaukee
- Cáncer (todos los tipos)22 estudios
- Cáncer de pulmón de células no pequeñas22 estudios
- Mieloma múltiple21 estudios
- Cáncer de pulmón21 estudios
- Cáncer de próstata20 estudios
- Linfoma folicular19 estudios
- Linfoma no Hodgkin18 estudios
- Cáncer de páncreas18 estudios
- Leucemia mielógena aguda17 estudios
- Cáncer de ovario17 estudios
- Linfoma difuso de células B grandes16 estudios
- Linfoma de Burkitt16 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.